KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Stratasys (SSYS) EBT (2016 - 2026)

Stratasys has reported EBT over the past 16 years, most recently at -$23.8 million for Q1 2026.

  • Quarterly EBT fell 117.73% to -$23.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$75.0 million through Mar 2026, down 4.59% year-over-year, with the annual reading at -$62.1 million for FY2025, 26.05% up from the prior year.
  • EBT was -$23.8 million for Q1 2026 at Stratasys, down from -$17.8 million in the prior quarter.
  • Over five years, EBT peaked at $24.0 million in Q3 2022 and troughed at -$42.1 million in Q3 2023.
  • The 5-year median for EBT is -$20.0 million (2025), against an average of -$16.0 million.
  • Year-over-year, EBT surged 259.19% in 2022 and then tumbled 275.74% in 2023.
  • A 5-year view of EBT shows it stood at $3.9 million in 2022, then skyrocketed by 66.97% to $6.5 million in 2023, then tumbled by 246.07% to -$9.5 million in 2024, then plummeted by 86.79% to -$17.8 million in 2025, then crashed by 33.78% to -$23.8 million in 2026.
  • Per Business Quant, the three most recent readings for SSYS's EBT are -$23.8 million (Q1 2026), -$17.8 million (Q4 2025), and -$20.0 million (Q3 2025).